Caredx
CareDx Inc is an American precision medicine company specializing in transplant patient genomics and diagnostic monitoring solutions. The company provides molecular diagnostic tests, donor-derived cell-free DNA assays, HLA typing reagents, and digital health software including AlloMap and AlloSure. Main revenue drivers consist of testing service fees for organ transplant surveillance billed to insurance providers and health systems alongside laboratory product sales. CareDx serves transplant cardiologists, nephrologists, clinical laboratories, transplant centers, and organ recipient patients across North America and Europe. The company holds a market-leading position in genomics-based transplant patient care and post-transplant monitoring. Headquartered in South San Francisco, California, CareDx Inc is listed on the Nasdaq Stock Market.
4 of the funds FundTelligence covers report a position in Caredx.
- Legal name
- CAREDX
- Sector
- Health Care
- Country
- United States
- Funds holding it
- 4
- Exposure themes
- Molecular Diagnostics, Precision Medicine & Genomics, Transplant Diagnostics
Funds holding Caredx
- BlackRock iShares Healthcare Innovation UCITS ETF — BlackRock · 0.37 % (full portfolio disclosed, October 2026)
- KLP AksjeGlobal Small Cap Flerfaktor — KLP · 0.17 % (full portfolio disclosed, June 2026)
- DNB Global Enhanced Small Cap — DNB · 0.04 % (full portfolio disclosed, September 2026)
- KLP AksjeGlobal Small Cap Indeks — KLP · 0.01 % (partially disclosed portfolio, June 2026)